Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1969 Apr 26;2(5651):202.

L-dopa in Parkinsonism.

PMCID: PMC1983096  PMID: 5780422

Full text

PDF

Page 202

202

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIRKMAYER W., HORNYKIEWICZ O. [The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis]. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1962;203:560–574. doi: 10.1007/BF00343235. [DOI] [PubMed] [Google Scholar]
  2. Calne D. B., Stern G. M., Laurence D. R., Sharkey J., Armitage P. L-dopa in postencephalitic parkinsonism. Lancet. 1969 Apr 12;1(7598):744–746. doi: 10.1016/s0140-6736(69)91751-6. [DOI] [PubMed] [Google Scholar]
  3. Cotzias G. C., Papavasiliou P. S., Gellene R. Modification of Parkinsonism--chronic treatment with L-dopa. N Engl J Med. 1969 Feb 13;280(7):337–345. doi: 10.1056/NEJM196902132800701. [DOI] [PubMed] [Google Scholar]
  4. Cotzias G. C., Van Woert M. H., Schiffer L. M. Aromatic amino acids and modification of parkinsonism. N Engl J Med. 1967 Feb 16;276(7):374–379. doi: 10.1056/NEJM196702162760703. [DOI] [PubMed] [Google Scholar]
  5. EHRINGER H., HORNYKIEWICZ O. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klin Wochenschr. 1960 Dec 15;38:1236–1239. doi: 10.1007/BF01485901. [DOI] [PubMed] [Google Scholar]
  6. Poirier L. J., Sourkes T. L., Bouvier G., Boucher R., Carabin S. Striatal amines, experimental tremor and the effect of harmaline in the monkey. Brain. 1966 Mar;89(1):37–52. doi: 10.1093/brain/89.1.37. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES